Simulation in In Vitro Bioequivalence for Particle Sizes
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore Simulation-informed design in in-vitro bioequivalence trials for particle size distributions’ performance.
Challenges in OINDPs Achieving Q3 Equivalence
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm review the bioequivalence challenges for OINDPs by achieving Q3 structural equivalence.